Literature DB >> 9357949

Pulmonary deposition of salbutamol aerosol delivered by metered dose inhaler, jet nebulizer, and ultrasonic nebulizer in mechanically ventilated rabbits.

T F Fok1, M Al-Essa, S Monkman, M Dolovich, L Girard, G Coates, H Kirpalani.   

Abstract

The deposition efficiency of three methods of aerosol delivery of salbutamol into lungs of ventilated rabbits was compared: 1) metered dose inhaler (MDI) with holding chamber (HC), 2) jet nebulizer (JN), and 3) ultrasonic (US) nebulizer. The latter system was tested using two different sized medication reservoirs, a large (20 mL) cup (US20) and a small (10 mL) cup (US10). After delivery of technetium-99m-labeled salbutamol aerosol, deposition in the lungs, trachea, and ventilator circuit were estimated by a gamma counter. Total pulmonary deposition [mean(SEM)] as a percentage of the prescribed drug was: MDI + HC 0.22(0.05)%; JN 0.48(0.05)%; US20 0.90(0.13)%; US10 3.05(0.49)%. Only the deposition from the US10 was statistically significantly higher than the other modes (p < 0.05). Dynamic scintigraphy showed that, among the nebulizers, the US10 continued to deliver medication for longer than either the JN or the US20. We conclude that the US10 appears to be more efficient in delivering aerosol to the lung in this rabbit model and merits further evaluation for clinical efficiency.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357949     DOI: 10.1203/00006450-199711000-00027

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Randomised controlled study of early use of inhaled corticosteroid in preterm infants with respiratory distress syndrome.

Authors:  T F Fok; K Lam; M Dolovich; P C Ng; W Wong; K L Cheung; K W So
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

2.  In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants.

Authors:  Connor Howe; Mohammad A M Momin; Karl Bass; Ghali Aladwani; Serena Bonasera; Michael Hindle; Philip Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2022-02-14       Impact factor: 3.440

3.  Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation.

Authors:  Connor Howe; Mohammad A M Momin; Ghali Aladwani; Michael Hindle; P Worth Longest
Journal:  Pharm Res       Date:  2022-10-17       Impact factor: 4.580

4.  Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease.

Authors:  T F Fok; K Lam; P C Ng; H K So; K L Cheung; W Wong; K W So
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

5.  Optimal delivery of aerosols to infants during mechanical ventilation.

Authors:  P Worth Longest; Mandana Azimi; Michael Hindle
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

6.  Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation.

Authors:  P Worth Longest; Geng Tian
Journal:  Pharm Res       Date:  2014-08-08       Impact factor: 4.200

7.  Development of an ex vivo respiratory pediatric model of bronchopulmonary dysplasia for aerosol deposition studies.

Authors:  Yoann Montigaud; Sophie Périnel; Jean-Christophe Dubus; Lara Leclerc; Marie Suau; Clémence Goy; Anthony Clotagatide; Nathalie Prévôt; Jérémie Pourchez
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

8.  A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation.

Authors:  Prakash Khadka; Jack Dummer; Philip C Hill; Rajesh Katare; Shyamal C Das
Journal:  Drug Deliv Transl Res       Date:  2022-09-21       Impact factor: 5.671

9.  Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.

Authors:  Connor Howe; Michael Hindle; Serena Bonasera; Vijaya Rani; P Worth Longest
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-08-04       Impact factor: 2.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.